Harvard Ave Acquisition Corporation (HAVAU) 股票分析
金融服务Harvard Ave Acquisition Corporation
$10.28
+$0.09 (+0.83%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Harvard Ave Acquisition Corporation operates within the financial services sector, specifically classified under the industry of shell companies, with a primary business focus on executing mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or similar business combinations with one or more external entities or businesses. As a specialized entity incorporated in 2024 and headquartered in Seoul, South Korea, the company functions as a potential merger vehicle designed to facilitate corporate restructuring or consolidation activities rather than maintaining ongoing operational revenue streams typical of traditional financial service firms. The company's current market capitalization stands at $185.60M, while its reported annual revenue for the trailing twelve months is not available, and the employee count is listed as N/A, indicating a highly lean organizational structure common for pre-transaction shell companies. These valuation and structural metrics suggest that the company's current position is defined by its potential for future business combination transactions rather than existing operational scale, with the market cap reflecting investor sentiment regarding its likelihood of completing a successful merger or acquisition rather than current profitability.
财务健康
The company's financial performance for the trailing twelve months reveals a net income of $-273,933, while revenue and EBITDA figures are not available, a situation typical for shell companies where operating expenses related to maintaining the corporate structure often exceed negligible or zero revenue. The gap between the non-existent or zero revenue and the negative net income highlights a cost structure driven by administrative overhead and legal fees associated with being a public shell entity, rather than costs tied to generating sales or services. Despite the negative net income, the company reports positive free cash flow of $4.04M, which provides a degree of financial flexibility by indicating that cash inflows from financing activities, likely from PIPE investments or sponsor funding, exceed cash outflows for operations. However, the company's liquidity position is constrained by a total cash balance of $965,240 against a debt obligation of $331,730, creating a net cash-positive balance sheet that is nonetheless modest in absolute terms. The balance sheet analysis shows a debt-to-equity ratio that is not available, but the current ratio of 0.23 indicates that the company's current assets are significantly lower than its current liabilities, suggesting tight short-term liquidity conditions. Furthermore, the return on equity is not available, while the return on assets stands at -0.2%, reflecting the fact that the company's assets are currently generating a loss rather than a return for shareholders. All three margin metrics—the gross margin, operating margin, and profit margin—are recorded at 0.0%, which is consistent with a business model that has not yet generated revenue from operations to support cost structures.
估值评估
Valuation metrics for Harvard Ave Acquisition Corporation present a mixed picture of market perception versus fundamental book value, as the trailing P/E ratio and forward P/E ratio are both not available due to the lack of positive earnings required to calculate these standard profitability multiples. In the absence of a positive P/E, the price-to-book ratio is reported at -56.22, a negative figure that indicates the market is valuing the company at a significant discount relative to its book value, often seen in distressed or pre-revenue shell companies where the market price is below the net asset value. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also not available, as the underlying revenue and earnings data required to compute these ratios are missing or negligible. The stock's trading range over the last year has fluctuated between a 52-week high of $11.03 and a 52-week low of $9.98, placing the current market price in a relatively narrow band near the lower end of this historical volatility range. The beta value is not available, which prevents a direct assessment of the stock's price volatility relative to the broader market index, though the narrow trading range suggests limited price movement compared to more active financial equities.
Growth & Income
Growth metrics for the company show that revenue growth year-over-year and earnings growth year-over-year are both not available, which is expected for a shell company that has not yet completed a business combination to generate organic growth or earnings expansion. Since the company does not pay dividends, the dividend yield and payout ratio are not available, indicating that the entity retains all capital and any available cash flows for potential use in transaction costs or future merger deposits rather than distributing income to shareholders. The company's financial profile is characterized by a reinvestment strategy where available cash, evidenced by the positive free cash flow, is preserved to fund the costs associated with seeking a target for merger or acquisition rather than being distributed as dividends. Overall, the growth and income profile of Harvard Ave Acquisition Corporation is currently defined by a lack of historical growth data and a reliance on external capital infusion rather than internal earnings generation or dividend distribution, positioning the asset as a speculative vehicle dependent on the successful execution of a future business combination.
同行比较
Harvard Ave Acquisition Corporation (HAVAU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Harvard Ave Acquisition Corporation | HAVAU | N/A | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Harvard Ave Acquisition Corporation的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Harvard Ave Acquisition Corporation
Harvard Ave Acquisition Corporation does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Seoul, South Korea.
公司简介以英文显示。